Chemical Compound
(2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide; (E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide; (E)-Entacapone; Comtan; OR 611; Entacapone; (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide
CAS Registry Number
130929-57-6
Primary record
(2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide; (E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide; (E)-Entacapone; Comtan; OR 611; Entacapone; (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide
- 库存
- 3,595 克
- 纯度
- 98.4 %
- CAS
- 130929-57-6
化合物标识与属性
- CAS
- 130929-57-6
- PubChem CID
- 5281081
- SMILES
- CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N
- Canonical SMILES
- CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1
名称与同义词
- ENTACAPONE
- Comtan
- Comtess
- Entacaponum
- Entacapona
- 130929-57-6
- Entacom
- Entacapone teva
- Entacapone orion
- (E)-Entacapone
- cis-Entacapone
- Entacapone?
- Entacapone RS
- Entacapone CRS
- Entacaponum [INN-Latin]
- Entacapona [INN-Spanish]
- Comtan (TN)
- Entacapone [USAN:INN]
- 5-Nitroisovanilline
- OR-611
- Stalevo (TN)
- CONTAM
- Entacapone (Standard)
- CHEMBL953
- ENTACAPONE [MI]
- RefChem:56991
- DTXSID5046439
- ENTACAPONE [INN]
- ENTACAPONE [JAN]
- Orion brand of entacapone
- ENTACAPONE [USAN]
- C14H15N3O5
- ENTACAPONE [VANDF]
- OR 611
- D0J1VY
- UNII-4975G9NM6T
- AC1NQY02
- ENTACAPONE [MART.]
- CHEBI:4798
- JRURYQJSLYLRLN-BJMVGYQFSA-N
- Novartis brand of entacapone
- 4975G9NM6T
- ENTACAPONE [USP-RS]
- ENTACAPONE [WHO-DD]
- MFCD00866580
- SCHEMBL34504
- DTXCID3026439
- BIDD:GT0026
- Entacapone (JAN/USAN/INN)
- ENTACAPONE [EMA EPAR]
- COM-998
- Entacapone (JP17/USP/INN)
- Entacapone [USAN:USP:INN:BAN]
- GTPL6647
- STALEVO COMPONENT ENTACAPONE
- CORBILTA COMPONENT ENTACAPONE
- ENTACAPONE [ORANGE BOOK]
- SCHEMBL29356206
- (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide
- HSDB 8251
- ENTACAPONE [EP MONOGRAPH]
- N04BX02
- ENTACAPONE [USP MONOGRAPH]
- GLXC-01688
- HMS2089O16
- HMS3713B20
- HMS3885K09
- HMS5081C20
- OR611
- (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide
- EX-A1130
- Tox21_112184
- (E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide
- 116314-67-1
- AC-393
- BDBM50108879
- EBC-07837
- HY-14280R
- NCGC00164555-01
- s3147
- ZINC35342787
- AKOS015907685
- AKOS015965009
- C14-H15-N3-O5
- Tox21_112184_1
- (E)-OR-611
- 2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide
- 2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-, (2E)-
- ACN-049982
- AN-5935
- BCP9000645
- CB11809
- CCG-213064
- CID5281081
- CS-1266
- DB00494
- FC22678
- CID:5281081
- NCGC00164555-02
- NCGC00164555-03
- NCGC00164555-10
- (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide
- BC219329
- HY-14280
- KB475572
- SID:53790856
- SY024802
- (E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide
- 2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-
- 3,4-dihydroxy-5-trifluoromethylbenzaldehyde
- AB0105766
- J506.416C
- LS-123327
- LS-172316
- RT-012475
- CAS-130929-57-6
- E0961
- FT-0631134
- FT-0667864
- N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide
- NS00006886
- SW199035-2
- (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide
- C07943
- D00781
- J90011
- K-4072
- AB01275450-01
- AB01275450_02
- AB01275450_03
- 929E576
- A806167
- A922031
- C071192
- Q416444
- SR-05000001452
- I14-2812
- SR-05000001452-1
- SR-05000001452-2
- SR-05000001452-3
- BRD-K83636919-001-01-4
- BRD-K83636919-001-03-0
- BRD-K83636919-001-04-8
- BRD-K83636919-001-05-5
- LEVODOPA/CARBIDOPA/ENTACAPONE ORION COMPONENT ENTACAPONE
- B0084-057038
- (E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide
- 2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide
- (~{E})-2-cyano-~{N},~{N}-diethyl-3-[3-nitro-4,5-bis(oxidanyl)phenyl]prop-2-enamide
- (E)-N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide
- alpha-Cyano-N,N-diethyl-3-nitro-4,5-dihydroxy-trans-cinnamamide
- N,N-Diethyl-alpha-cyano-3,4-dihydroxy-5-nitro-trans-cinnamamide
- (2E)-2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propeneamide
- (E)-.ALPHA.-CYANO-N,N-DIETHYL-3,4-DIHYDROXY-5-NITROCINNAMAMIDE
- (E)-2-CYANO-3-(5-(DIHYDROXYAMINO)-3,4-DIOXOCYCLOHEXA-1,5-DIENYL)-N,N-DIETHYLACRYLAMIDE
- (E)-2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide
- (E)-N, N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide
- 1047659-02-8
- 2-Propenamide,2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-,(2E)-
- (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide; (E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide; (E)-Entacapone; Comtan; OR 611; Entacapone; (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide
- (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-bis(1,1,2,2,2-pentadeuterioethyl)prop-2-enamide
- 145195-63-7
- 686349-59-7
- PD9